Colgate-Palmolive (NYSE:CL) Given New $90.00 Price Target at UBS Group

Colgate-Palmolive (NYSE:CL) had its price target decreased by UBS Group from $92.00 to $90.00 in a research report released on Monday,Benzinga reports. UBS Group currently has a buy rating on the stock.

Several other analysts have also recently issued reports on the company. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Colgate-Palmolive in a research report on Wednesday, October 8th. The Goldman Sachs Group dropped their target price on Colgate-Palmolive from $106.00 to $91.00 and set a “buy” rating on the stock in a research report on Thursday, October 2nd. Citigroup dropped their target price on Colgate-Palmolive from $105.00 to $95.00 and set a “buy” rating on the stock in a research report on Monday. Wells Fargo & Company dropped their target price on Colgate-Palmolive from $80.00 to $77.00 and set an “underweight” rating on the stock in a research report on Monday. Finally, Morgan Stanley dropped their target price on Colgate-Palmolive from $96.00 to $87.00 and set an “overweight” rating on the stock in a research report on Monday. Nine equities research analysts have rated the stock with a Buy rating, five have assigned a Hold rating and one has issued a Sell rating to the company. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $90.00.

Colgate-Palmolive Trading Down 2.7%

CL opened at $74.94 on Monday. The stock’s fifty day moving average is $80.26 and its two-hundred day moving average is $86.14. The company has a market capitalization of $60.56 billion, a P/E ratio of 21.05, a PEG ratio of 4.44 and a beta of 0.34. Colgate-Palmolive has a 52 week low of $74.54 and a 52 week high of $100.18. The company has a quick ratio of 0.57, a current ratio of 0.89 and a debt-to-equity ratio of 6.79.

Colgate-Palmolive (NYSE:CL) last released its quarterly earnings data on Friday, October 31st. The company reported $0.91 EPS for the quarter, topping the consensus estimate of $0.89 by $0.02. The company had revenue of $5.13 billion for the quarter, compared to the consensus estimate of $5.17 billion. Colgate-Palmolive had a return on equity of 377.63% and a net margin of 14.55%.Colgate-Palmolive’s quarterly revenue was up 1.9% on a year-over-year basis. During the same period last year, the business posted $0.91 EPS. Analysts forecast that Colgate-Palmolive will post 3.75 earnings per share for the current year.

Colgate-Palmolive Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, November 14th. Shareholders of record on Friday, October 17th will be given a dividend of $0.52 per share. The ex-dividend date of this dividend is Friday, October 17th. This represents a $2.08 dividend on an annualized basis and a yield of 2.8%. Colgate-Palmolive’s payout ratio is currently 58.26%.

Hedge Funds Weigh In On Colgate-Palmolive

A number of institutional investors have recently modified their holdings of CL. Personal CFO Solutions LLC acquired a new stake in Colgate-Palmolive in the first quarter valued at $285,000. Vision Capital Management Inc. acquired a new stake in Colgate-Palmolive in the first quarter valued at $322,000. Financial Gravity Asset Management Inc. purchased a new position in shares of Colgate-Palmolive during the first quarter worth about $2,166,000. Cidel Asset Management Inc. grew its holdings in shares of Colgate-Palmolive by 13.6% during the second quarter. Cidel Asset Management Inc. now owns 329,060 shares of the company’s stock worth $29,912,000 after purchasing an additional 39,413 shares during the last quarter. Finally, Penserra Capital Management LLC grew its holdings in shares of Colgate-Palmolive by 398.6% during the first quarter. Penserra Capital Management LLC now owns 10,651 shares of the company’s stock worth $997,000 after purchasing an additional 8,515 shares during the last quarter. Hedge funds and other institutional investors own 80.41% of the company’s stock.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.